Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report ; volume:19 ; number:1 ; day:14 ; month:11 ; year:2019 ; pages:1-5 ; date:12.2019
BMC cancer ; 19, Heft 1 (14.11.2019), 1-5, 12.2019
- Creator
-
Calapre, Leslie
Warburton, Lydia
Millward, Michael
Gray, Elin S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-6336-3
- URN
-
urn:nbn:de:101:1-2020031223484169931131
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Calapre, Leslie
- Warburton, Lydia
- Millward, Michael
- Gray, Elin S.
- SpringerLink (Online service)
Other Objects (12)
Circulating Tumour DNA in Melanoma—Clinic Ready?
Detection of metastases using circulating tumour DNA in uveal melanoma
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Unravelling mutational signatures with plasma circulating tumour DNA
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients
Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
Circulating Tumour DNA in Melanoma—Clinic Ready?
Detection of metastases using circulating tumour DNA in uveal melanoma
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Unravelling mutational signatures with plasma circulating tumour DNA
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients
Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
Circulating Tumour DNA in Melanoma—Clinic Ready?
Detection of metastases using circulating tumour DNA in uveal melanoma
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Unravelling mutational signatures with plasma circulating tumour DNA
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients
Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA